You just read:

Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access

News provided by

Genomic Health, Inc.

Sep 13, 2017, 01:00 ET